Please login to the form below

Not currently logged in
Email:
Password:

Spiolto Respimat

This page shows the latest Spiolto Respimat news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

fibrosis treatmentRespimat in COPD and Spiriva Respimat for asthma.

Latest news

  • Boehringer hails its 'landmark year' in respiratory Boehringer hails its 'landmark year' in respiratory

    We are also looking at Spiriva Respimat in paediatric asthma patients because there is an unmet medical need there.”. ... Spiolto is positioned as offering greater benefits for patients and physicians than Spiriva and was approved in its first European

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...